Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
126.45B | 115.81B | 105.00B | 96.07B | 82.45B | 86.80B | Gross Profit |
34.83B | 32.40B | 27.13B | 23.95B | 21.69B | 22.82B | EBIT |
15.92B | 15.30B | 11.48B | 9.81B | 8.05B | 9.09B | EBITDA |
16.98B | 16.58B | 12.78B | 11.17B | 9.80B | 10.36B | Net Income Common Stockholders |
12.21B | 12.31B | 8.65B | 8.17B | 6.30B | 6.23B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
56.93B | 54.24B | 46.39B | 44.16B | 39.92B | 31.70B | Total Assets |
141.54B | 130.53B | 113.00B | 103.70B | 96.91B | 88.32B | Total Debt |
0.00 | 0.00 | 0.00 | 1.00M | 1.00M | 125.00M | Net Debt |
-56.93B | -54.24B | -46.39B | -44.16B | -39.92B | -31.57B | Total Liabilities |
41.85B | 37.71B | 33.09B | 31.79B | 32.21B | 30.21B | Stockholders Equity |
99.02B | 92.71B | 79.83B | 71.85B | 64.66B | 58.05B |
Cash Flow | Free Cash Flow | ||||
0.00 | 10.20B | 3.50B | 5.21B | 9.50B | -891.00M | Operating Cash Flow |
0.00 | 12.58B | 5.51B | 6.57B | 11.18B | 5.14B | Investing Cash Flow |
0.00 | -2.88B | -2.26B | -1.50B | -1.65B | -6.45B | Financing Cash Flow |
0.00 | -2.29B | -1.24B | -1.06B | -1.09B | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $10.78T | 43.92 | 10.53% | 0.68% | 7.95% | 10.56% | |
75 Outperform | €6.27T | 19.18 | 8.40% | 1.69% | 5.02% | 14.73% | |
73 Outperform | $1.54T | 17.48 | 12.94% | 1.56% | 15.14% | 246.85% | |
71 Outperform | €74.48B | 10.93 | 5.47% | 2.47% | 6.71% | -37.02% | |
69 Neutral | ¥63.55B | 7.37 | 5.14% | -0.69% | 8.49% | ||
68 Neutral | ¥127.99B | 9.99 | 2.43% | 12.12% | 5.56% | ||
65 Neutral | $4.41B | 12.06 | 5.22% | 249.80% | 4.09% | -12.16% |